Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Uncontrolled Type 1 Diabetes
NCT01592279Phase 4Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jun 2012
- Primary completion
- Jun 2014
- Modality
- Peptides
01
Overview
A Phase 4 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01592279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01592279.